return to CNTN

    Publications | Abstracts

Anderson AM, Tang B, Vaida F, Okwuegbuna O, McClernon D, Deutsch R, Kundu S, Cherner M, Cookson D, Crescini M, Grant I, Ellis RJ, Letendre SL.  CSF CXCL10 is associated with the presence of low-level CNS HIV during ART. Conference on Retroviruses and Opportunistic Infections, 03-09-2020.
 Dubé K, Nathan A, Mathur K, Concha-Garcia S, Patel H, Kaytes A, Taylor J, Smith D, Gianella S.  (2019). Altruism in end of life HIV research: Insights from the Last Gift Study. CROI
 Oliveira M, Murrell B, Vollbrecht T, Concha-Garcia S, Kumar V, Porrachia M, Scott B, Laymman L, Ignacio K, Smith D, Gianella S.  (2019). Characterizing the HIV DNA Reservoirs in Whole-Body Tissues in the Last Gift Cohort. CROI
Bumpus N, Ma Q, Best B, Moore D, Ellis RJ, Crescini M, Achim C, Fletcher C, Masliah E, Grant I, and Letendre S, for the CNTN Group.  Antiretroviral concentrations in brain tissue are similar to or exceed those in CSF. 13th International Symposium on NeuroVirology, 06-02-2015.
 Bumpus N.  (2015). Antiretroviral drug concentrations in human brain tissue are similar or exceed historical concentrations in CSF. 2015 Annual Conference on Retrovises and Opportunistic Infections
 Levine AJ, Soontornniyomkij V, Achim CL, Gouaux B, Masliah E, Sinsheimer J, Singer E, Moore DJ.  (2015). Bridging genetics, histopathology, and neurocognition in the context of HAND. 2015 Conference on Retroviruses and Opportunistic Infections
 Teodorof C, Nguyen D, Kadakia N, Maung R, Soontornniyomkij B, Achim CL, Moore D, Masliah E, Kaul M, Singh K.  (2015). MBL-HIV1gp120 immunoreactivity is associated with markers of neuronal injury. 2015 Conference on Retroviruses and Opportunistic Infections
 Soontornniyomkij V, Umlauf A, Soontornniyomkij B, Batki I, Gouaux B, Moore DJ, Masliah E, Grant I, Achim CL.  (2015). Methamphetamine dependence is associated with cerebral microgliosis in HIV-infected individuals. 13th International Symposium on NeuroVirology
 Soontornniyomkij V, Umlauf A, Soontornniyomkij B, Gouaux B, Toperoff W, Moore DJ, Masliah E, Grant I, Achim CL.  (2014). Cerebral small vessel disease and HAND in ARV-treated subjects. 21st Conference on Retroviruses and Opportunistic Infections
 Soontornniyomkij V, Umlauf A, Achim CL, and Grant I.  (2014). Effects of anti-HIV therapy on cerebral small vessel disease. 9th Annual Lewis L. Judd Young Investigators Research Symposium
Grant I, Sherman S, Morgello S, Singer E, Fox H, Gelman B, Brandt D.  National NeuroAIDS Tissue Consortium: Enabling studies on HAND neuropathogenesis. 20th International AIDS Conference, 07-20-2014.
 Bryant AK, Ellis RJ, Umlauf A, Gouaux B, Soontornniyomkij V, Letendre SL, Achim C, Masliah E, Grant I, and Moore DJ.  (2014). Virally suppressive antiretroviral therapy protects against cortical neurodegeneration and HIV-associated neurocognitive disorders. 2014 American Neurological Association 139th Annual Meeting
 Fields J, Eleuteri S, Kosberg K, Adame A, Masliah E.  (2013). C/EBPβ expression in the brain during HIV infection: Implications for neuronal autophagy. Society for Neuroscience
 Soontornniyomkij V, Umlauf A, Chung SA, Cochran ML, Soontornniyomkij B, Gouaux B, Toperoff W, Bucci A, Moore DJ, Masliah E, Ellis RJ, Letendre SL, Jeste DV, Grant I, Achim CL.  (2013). Effect of central nervous system antiretroviral penetration on HIV-associated neurocognitive disorders. 12th International Symposium on NeuroVirology
 Levine A, Achim C, Singer E, Masliah E, Sinsheimer J, Soontornniyomkij V, Moore DJ.  (2013). Establishing a Link Between Host Genotype and HIV-related neuropathology – A novel approach to understanding neuropathogenesis. Mid-Year Meeting International Neuropsychological Society
 Fields J, Eleuteri S, Kosberg K, Adame A, Masliah E.  (2013). HIV-1 viral proteins disrupt neuron autophagy function and autophagosome formation: Mechanisms in HIV-associated neurocognitive disorders. Society for Neuroimmune Pharmacology
Perez-Valero I, Letendre S, Deutsch R, Heaton R, Clifford DB, McArthur J, Morgello S, Gelman B, Collier A, Grant I, the CHARTER Group, and the HNRP Group.  Incidence, risk factors and neurocognitive impact of CSF viral escape: Longitudinal analysis of the CHARTER & HNRP Cohorts. 20th Conference on Retroviruses and Opportunistic Infections, 03-05-2013.
Rooney A, Gouaux B, Ellis R, Grant I, Moore DJ, and the CNTN Group.  Is diagnosis of asymptomatic neurocognitive impairment (ANI) a predictor of death? National Academy of Neuropsychology 33rd Annual Conference, 10-16-2013.
 Gelman B, Lisinicchia J, Morgello S, Maslia E, Commins D, Grant I, Singer E, Sherman S, Gensler G, Soukup V, and NNTC.  (2013). Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART era cohort. 20th Conference on Retroviruses and Opportunistic Infections
 Tran D, Kumar N, Teodorof C, Adame A, Gouaux B, Moore D, Dumaop W, Michael S, Masliah E, Singh K, and the HNRP Group.  (2013). Novel MBL-beta amyloid interactions in HIV-1 infected brain: Implications for HIV related aging and Alzheimer’s Disease. 20th Conference on Retroviruses and Opportunistic Infections
Saijo K, Moore D, Gouaux B, Grant I, Ellis R.  Reduced Δ5-ADIOL in CSF and Plasma as a Biomarker of Neurocognitive Impairment in HIV Infection. 65th American Academy of Neurology Annual Meeting in San Diego, 03-16-2013.
Haughey N, Mielke M, Bandaru V, Sacktor N, Grant I, Letendre S, Fox H, Chang L, Wozna V, Pardo C, McArthur J.  A lipidomic analysis of CSF from HIV-infected subjects identifies metabolites that predict change in cognitive performance. 19th Conference on Retroviruses and Opportunistic Infections, 03-05-2012.
 Perez-Santiago J, Plongthongkum N, Letendre S, Ellis R, Gouaux B, Moore D, LeBlanc S, Rajagopal N, Zhang K, Woelk C.  (2012). DNA methylation correlates with neurological decline in HIV-infected individuals. 19th Conference on Retroviruses and Opportunistic Infections
Ferrara M, Umlauf A, FitzSimons C, Meyer J, Duarte N, Atkinson JH, Grant I, Ellis R, for the CHARTER Group.  Effect of second generation antipsychotics on metabolic variables in HIV-infected adults on long term antiretroviral therapy. International AIDS Conference, Washington, DC, 07-22-2012.
Gelman B, Chen T, Lisinicchia J, Commins D, Masliah E, Grant I, Singer E, Achim C, Sherman S, Gensler G, Brant D, Yiannoutsos C, Fox H, Morgello S.  (2012). HIV-1 RNA but not DNA in NNTC brain specimens is correlated with neurocognitive impairment. Journal of NeuroVirology, 18(Suppl 1), S39. 
 Nathamu S, Adame A, Dumaop W, Gouaux B, Moore D, Masliah E, Singh K, and the HNRC Group.  (2012). Increased expression of complement receptor 2 and ligand C3 deposition in HIV encephalitis: A potential link to innate and adaptive immune responses in NeuroAIDS. 19th Conference on Retroviruses and Opportunistic Infections
 Nathamu S, Adame A, Dumoap W, Gouaux B, Moore D, Masliah E, Singh K, and the HNRC Group.  (2012). Lectin complement pathway activation is linked to immune complex deposition in HIV encephalitis. 19th Conference on Retroviruses and Opportunistic Infections
Tatro ET, Hefler S, Shumaker S, Yang M, Soontornyiomkij B, Achim C.  MicroRNA-9 is increased in CNS HIV-infection and methamphetamine exposure. 11th International Symposium on NeuroVirology, 05-29-2012.
Achim C, Soontornniyomkij B, Moore DJ, Gouaux B, Tung S, Vinters HV, Masliah E, Grant I, Soontornniyomkij B.  (2012). Neuronal sestrin-2 response to oxidative stress in HIV associated neurocognitive disorders. Journal of NeuroVirology, 18(Suppl 1), S2. 
Pérez-Valero I, Letendre S, Ellis R, Deutsch R, Franklin D, Clifford DB, Heaton R, McCutchan J, McArthur J, Morgello S, Gelman B, Collier A, Grant I, and the CHARTER & HNRP Groups.  Prevalence and risk factors for HIV CSF viral escape: Results from the CHARTER and HNRP cohorts. 11th International Congress on Drug Therapy, Glasgow, Scotland, 11-11-2012.
Letendre S, Harezlak J, Taylor M, Schifitto G, Daar E, Campbell T, Rosario D, Gualtieri L, Yiannoutsos C, Navia B, for the HIV NeuroImaging Consortium.  Biomarkers of immune activation contribute to patterns of neural injury in HIV-infected patients on stable ART: An in vivo proton MRS study. 18th Conference on Retroviruses and Opportunistic Infections, Boston, Mass, 02-28-2011.
Nathamu S, Adame A, Dumaop W, Gouaux B, Moore D, Grant I, Masliah E, Singh K, and the HNRC Group.  Higher Expression and Co-localization of Complement Receptor 2 and C3d Ligand with Neuroinflammatory Marker MCP-1 and Viral gp120/gp41 Proteins in HIV Encephalitis. Pediatric Translational Research Symposium, Rady’s Children Hospital, 10-25-2011.
 Singh K, Nathamu S, Adame A, Alire T, Dumaop W, Gouaux B, Moore DJ, Masliah E, and the HNRC Group.  (2011). Increased expression of Mannose Binding Lectin in HIV-1 infected brain: Implications for HIV related neuronal damage and encephalitis. 18th Conference on Retroviruses and Opportunistic Infections
 Tatro ET, Shumaker S, Moore DJ, Grant I, Achim CL.  (2011). Neurocognitive correlates of miRNA expression in the CNS of HIV positive subjects with a history of methamphetamine abuse. RNAi World Congress. Boston, MA, April 26-27th
 Gelman B, Chen T, Soukup V, Starkey J, Masliah E, Commins D, Brandt D, Singer E, Grant I, S Morgello.  (2010). NNTC gene array reveals brain adaptations and two different kinds of HIV-associated neurocognitive disorder. 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA
 Tatro E, Nguyen T, Scott E, Masliah E, Achim C, Everall I.  (2009). Alteration of gene regulatory networks through miRNA expression in the HIVinfected brain. Society for Neuroscience, Chicago, Illinois, October 17-21
Tatro ET, Scott ER, Nguyen TL, Masliah E, Everall IP, Achim CL.  (2009). Alterations of gene regulatory networks through microRNAs in the frontal cortex of HIV-infected individuals. 9th International Symposium on Neurovirology, Miami, Florida, 15(S1)
Achim CL, Soontornniyomkij V, Kaul M, Tatro E, Moore DJ, Everall IP, Grant I, Masliah E.  (2009). Brain immunophilin response in HIV infected METH users. Journal of NeuroVirology, 15(S1), 2. 
 Tatro ET, Scott ER, Nguyen TL, Masliah E, Achim CL, Everall IP.  (2009). Evidence for disrupted gene regulatory networks through microRNA`s in frontal cortex of HIV, MCMD, and Major Depressive Disorder. 1st Trends in Psychiatric Genetics, Breckenridge, Colorado
 Nguyen T, Tatro E, Kwok J, Bousman C, Soontornniyomkij, Grant I, Achim C, Everall I.  (2009). Immunophilins FKBP4 and FKBP5 as potential state-markers for major depressive disorder in HIV patients. Society for Neuroscience, Chicago, Illinois, October 17-21
 Everall I, Vaida F, Lazzaretto D, Letendre S, Ellis R, Gelman B, Morgello S, Singer E, Grant I, Masliah E.  (2009). The Neuroepidemiology of HIV in the United States in the Era of Antiretroviral (ARV) from the National NeuroAIDS Tissue Consortium (NNTC). 16th Conference on Retroviruses and Opportunistic Infections, Session 155
 Lucero GR, Chana G, Hult BJ, Tatro ET, Achim CL, Masliah E, Grant I, Everall IP.  (2008). GSK-3ß specific inhibitors provide neuroprotection against gp-120-mediated toxicity. Society for Biological Psychiatry Annual Meeting, Washington, DC, , 274. 
Everall I, Vada F, Letendre S, Lazzaretto D, Gelman B, Morgello S, Singer E, Ellis R, Masliah E, Grant I, the National NeuroAIDS Tissue Consortium, and the HNRC Group.  (2008). Reducing the prevalence of primary HIV brain pathology by antiretrovirals. 15th Annual Conference on Retroviruses and Opportunistic Infections, Session 20, 67. 
Moore DJ, Masliah E, Heaton RK, Grant I, and the HNRC Group.  (2007). Regional neurodegeneration in relation to learning and memory difficulties among HIV-infected individuals. Journal of the International Neuropsychological Society, 13(S1), 180-181. 
 Grant I, Gelman BB, Morgello S, Singer EJ.  (2003). National NeuroAIDS Tissue Consortium [NNTC]. Journal of NeuroVirology, 9(3), 113. 
 Moore DJ, Cherner M, Masliah E, Gonzalez R, Carey C, Gongvatana A, Marcotte TD, Heaton RK, Grant I, and the HNRC Group.  (2003). Neuropsychological impairment predicts multi-region HIV-related neurodegeneration. Journal of the International Neuropsychological Society, 9(2), 286. 
Marquie-Beck J, Ellis R, Langford D, Childers M, Rippeth J, Letendre S, Lazzaretto D, Masliah E.  (2003). Validation of post-mortem CSF viral load by comparison to ante-mortem viral load and clinical measurements. Journal of NeuroVirology, 9, 130. 
 Rivera Mindt M, Letendre S, Cherner M, Langford T, Masliah E, Heaton R, Jernigan T, Marcotte T, Grant I.  (2002). A case study of HIV encephalitis: the utility of neuropsychologic (NP), neuromedical (NM), neuroimaging (NI) evaluations in detecting early HIV brain involvement. Journal of NeuroVirology, 8(Suppl. 1), 148. 
Moore DJ, Cherner M, Masliah E, Gonzalez R, Carey C, Rippeth J, Marcotte T, Heaton RK, Grant I, and the HNRC Group.  (2002). Neuropsychological ability and regional neuropathology in HIV. Journal of the International Neuropsychological Society, 8(2), 187-188. 
 Cherner M, Moore DJ, Masliah E, Ellis R, Heaton RK, Grant I, and the HNRC Group.  (2002). Relationship between neuropsychological impairment and post-mortem findings of HIV-associated brain disease. Journal of the International Neuropsychological Society, 8(2), 314. 
Cherner M, Masliah E, Heaton R, Ellis R, Grant I, and the HNRC Group.  (2001). Value of neurocognitive status in predicting HIV-related brain disease. Journal of the International Neuropsychological Society, 7(2), 150. 
 Oliveira M, Murrell B, Vitomirov A, Vollbrecht T, Kumar V , Kumar N, Gouaux B, Moore D, Jarmush A, Vargas F, Dorrestein D, Ellis R, Smith D, Gianella S.  (). Presence of Intact HIV DNA Variants in the Brain and Lymphoid Tissues during ART. CROI